A TLR4-Targeting Bioactive Peptide Hydrogel to Regulate Immune-Microenvironment for Diabetic Wound Repair

Area of Science:

• Biomaterials Science
• Immunology
• Wound Healing Research

Background:

• Diabetic wound healing is impaired by persistent inflammation and poor immunoregulation.
• Current treatments often require complex, costly interventions like cytokine and cell therapies.
• Developing single-component immunoregulatory hydrogels presents a significant challenge.

Purpose of the Study:

• To engineer an active peptide hydrogel with immunoregulatory properties targeting the TLR4/NF-kB pathway.
• To promote rapid diabetic wound healing using a novel single-component hydrogel.
• To address limitations of current complex and expensive diabetic wound treatments.

Main Methods:

• Designed a peptide hydrogel (NFA) using naphthalene derivative, phenylalanine, and glycine for modulated characteristics.
• Incorporated arginine for enhanced tissue adhesion and gel stability.
• Characterized NFA hydrogel formation via physical crosslinking of self-assembled nanofibers in water.

Main Results:

• NFA hydrogel exhibited excellent injectability and tissue adhesion.
• NFA demonstrated significant potential in promoting full-thickness wound healing in a mouse model.
• The hydrogel effectively regulated macrophage responses within the inflammatory microenvironment via the TLR4/NF-kB pathway.

Conclusions:

• The engineered NFA peptide hydrogel shows promise as an effective therapeutic for diabetic wound healing.
• NFA hydrogel offers a simplified, potentially lower-cost approach compared to existing treatments.
• Targeting the TLR4/NF-kB pathway with NFA hydrogel is a viable strategy for improving diabetic wound repair.